Rimpy Chemical Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 20-12-2024
- Paid Up Capital ₹ 1.41 M
as on 20-12-2024
- Company Age 26 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.90 M
as on 20-12-2024
- Satisfied Charges ₹ 1.00 M
as on 20-12-2024
- Revenue 11.52%
(FY 2023)
- Profit 13.05%
(FY 2023)
- Ebitda 147.68%
(FY 2023)
- Net Worth 18.48%
(FY 2023)
- Total Assets 3.63%
(FY 2023)
About Rimpy Chemical
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.41 M.
The company currently has active open charges totaling ₹4.90 M. The company has closed loans amounting to ₹1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Deepak Agarwal and Saurabh Agarwal serve as directors at the Company.
- CIN/LLPIN
U22110UP1998PTC023853
- Company No.
023853
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Sep 1998
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- LocationUttar Pradesh, Uttar Pradesh
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rimpy Chemical?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Agarwal  | Director | 17-Nov-1998 | Current |
| Saurabh Agarwal | Director | 17-Sep-1998 | Current |
Financial Performance of Rimpy Chemical.
Rimpy Chemical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.52% increase. The company also saw a substantial improvement in profitability, with a 13.05% increase in profit. The company's net worth Soared by an impressive increase of 18.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rimpy Chemical?
Unlock access to Rimpy Chemical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Allahabad Bank Creation Date: 28 Dec 2011 | ₹4.90 M | Open |
U.P.Financial Carporation Creation Date: 18 Mar 2000 | ₹1.00 M | Satisfied |
How Many Employees Work at Rimpy Chemical?
Rimpy Chemical has a workforce of 6 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rimpy Chemical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rimpy Chemical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
